Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population

References

• Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177–e188.
   PubMed Web of Science ®Google Scholar
• Zhang XW, Li F, Yu XW, et al. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol. 2007;40(3):180–185.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang T, Zhang W, et al. Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China. Medicine (Baltimore). 2017;96(5):e6007.
   PubMed Web of Science ®Google Scholar
• Collaborative Team for the Study of Maternal and Infantile Cytomegalovirus Infection in Beijing. Prospective study on the impact of infantile cytomegalovirus infection on growth and development of infants. Chinese Journal of Pediatrics. 2010;48(5):385–389.
   Google Scholar
• Huang Y, Song Q, Guo X, et al. Risk factors associated with the vertical transmission of cytomegalovirus in seropositive pregnant women. Future Virol. 2019;14(4):265–273.
   Web of Science ®Google Scholar
• Huang X, Li JJ, Ge SX, et al. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen. J Virol Methods. 2017;240:21–25.
   Web of Science ®Google Scholar
• Huang Y, Wang H, Li T, et al. Comparison of detection strategies for screening and confirming congenital cytomegalovirus infection in newborns in a highly seroprevalent population: a mother-child cohort study. Lancet Reg Health West Pac. 2021:12:100182.
   Google Scholar
• Leruez-Ville M, Magny JF, Couderc S, et al. Risk factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase chain reaction in Saliva. Clin Infect Dis. 2017;65(3):398–404.
   PubMed Web of Science ®Google Scholar
• Kharrazi M, Hyde T, Young S, et al. Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection. J Pediatr. 2010;157(2):191–197.
   PubMed Web of Science ®Google Scholar
• Fowler KB, Pass RF. Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics. 2006;118(2):e286–e292.
   PubMed Web of Science ®Google Scholar
• Dorfman JR, Balla SR, Pathirana J, et al. In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection. Clin Infect Dis. 2021;73(4):e981–e987.
   Web of Science ®Google Scholar
• de Vries JJ, van Zwet EW, Dekker FW, et al. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol. 2013;23(4):241–249.
   PubMed Web of Science ®Google Scholar
• Mussi-Pinhata MM, Yamamoto AY, Moura Brito RM, et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis. 2009;49(4):522–528.
   PubMed Web of Science ®Google Scholar
• Yamamoto AY, Castellucci RA, Aragon DC, et al. Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol Infect. 2013;141(10):2187–2191.
   Web of Science ®Google Scholar
• Goderis J, De Leenheer E, Smets K, et al. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134(5):972–982.
   PubMed Web of Science ®Google Scholar
• Delforge ML, Costa E, Brancart F, et al. Presence of cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection. J Clin Virol. 2017;90:14–17.
   Web of Science ®Google Scholar
• Huang Y, Guo X, Song Q, et al. Cytomegalovirus shedding in healthy seropositive female college students: A 6-month longitudinal study. J Infect Dis. 2018;217(7):1069–1073.
   PubMed Web of Science ®Google Scholar
• Li TD, Li JJ, Huang X, et al. Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population. Eur J Clin Microbiol Infect Dis. 2016;36(5):863–868.
   Web of Science ®Google Scholar
• Blázquez-Gamero D, Soriano-Ramos M, Vicente M, et al. Prevalence and clinical manifestations of congenital cytomegalovirus infection in a screening program in Madrid (PICCSA study). Pediatr Infect Dis J. 2020;39(11):1050–1056.
   PubMed Web of Science ®Google Scholar
• Eventov-Friedman S, Manor H, Bar-Oz B, et al. Saliva real-time polymerase chain reaction for targeted screening of congenital cytomegalovirus infection. J Infect Dis. 2019;220(11):1790–1796.
   Web of Science ®Google Scholar
• Putri ND, Wiyatno A, Dhenni R, et al. Birth prevalence and characteristics of congenital cytomegalovirus infection in an urban birth cohort, Jakarta, Indonesia. Int J Infect Dis. 2019;86:31–39.
   PubMed Web of Science ®Google Scholar
• Nagel A, Dimitrakopoulou E, Teig N, et al. Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay. PLoS One. 2020;15(1):e0227143.
   Web of Science ®Google Scholar
• Pesch MH, Kuboushek K, McKee MM, et al. Congenital cytomegalovirus infection. Br Med J. 2021;373:n1212.
   Google Scholar